Consolidated guidelines on HIV testing services for a changing epidemic
27 November 2019
| Publication
Overview
These consolidated guidelines bring together existing and new evidence-based guidance and recommendations for delivering high-impact HIV testing services, including linkage to HIV prevention and treatment, in diverse settings and populations.
A key objective of these guidelines is to encourage greater national and global commitment to implementing effective and efficient HTS as a vital element of the national and global HIV response, essential to achieving and maintaining low HIV incidence.
Guidelines
Consolidated guidelines on HIV testing servicesPowerpoint presentation
- HTS guidelines: new guidance, recommendations and good practice - Part 1, PPT, 7.8MB
- HTS guidelines: new guidance, recommendations and good practice - Part 2, PPT, 7.9MB
Related policy briefs
- WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms
- WHO recommends social network-based HIV testing approaches for key populations as part of partner services package
- Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care
- What works for generating demand for HIV testing services
- WHO recommends HIV self-testing – evidence update and considerations for success
- WHO encourages countries to adapt HIV testing strategies in response to changing epidemic
Web annexes
- Annex A - GRADE Table: Which demand creation approaches are effective for increasing uptake of HIV testing and onward linkage to prevention, treatment and care? (PDF, 654 KB)
- Annex B - GRADE Table: Should HIV self-testing be offered as an additional HIV testing approach? (PDF, 619 KB)
- Annex C - GRADE Table: Should social network-based approaches be offered as an additional HIV testing approach for key populations and their contacts? (PDF, 437 KB)
- Annex D - GRADE Table: Should western blotting and line immunoassays be used in national testing strategies and algorithms? (PDF, 665 KB)
- Annex E - Abstract: Performance of HIV testing strategies: considerations for global guideline development (PDF, 299 KB)
- Annex F - Abstract: Modelling the cost-effectiveness of maternal HIV retesting in high- and low-HIV burden settings (PDF, 388 KB)
- Annex G - Abstract: Modelling the cost-effectiveness of using HIV/syphilis dual tests in antenatal care in high and low HIV burden settings (PDF, 240 KB)
- Annex H - Considerations for monitoring HIV testing services programmes (PDF, 253 KB)
- Annex I - In vitro diagnostics for HIV diagnosis (PDF, 313 KB)
- Annex J- Ensuring the quality of HIV testing services (PDF, 276 KB)
- Annex K - Global examples of HIV testing services (PDF, 1.7 MB)
- Annex L - Symptom and risk-based screening to optimize HIV testing services: a scoping review (PDF, 727 KB)
WHO Team
Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
Number of pages
12
Reference numbers
WHO Reference Number: WHO/CDS/HIV/19.31
Copyright
WHO